Australia's Genetic Signatures hits nearly 5-1/2-year low on discounted capital raise
** Shares of Genetic Signatures GSS.AX slip as much as
2.3% to A$0.430, hitting their lowest level since Aug 2, 2018
** Medical equipment and technology co says it's undertaking
a capital raising of about A$15.9 mln ($10.72 mln)
** Issue price of A$0.37 per share is at a 15.9% discount to
stock's last close on Dec 18
** Co says proceeds will be used to fund growth initiatives
including U.S. regulatory clearances
** GSS stock down 50% YTD, as of last close
($1 = 1.4839 Australian dollars)
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes